Evidence map›Paper›PMID 33767201›Full record

ArticleScientific data2021

An updated map of Trypanosoma cruzi histone post-translational modifications.

Rafael Fogaça de Almeida, Matheus Fernandes, Lyris Martins Franco de Godoy

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rafael Fogaça de AlmeidaInstituto Carlos Chagas, Fiocruz Parana, Curitiba, Parana, Brazil.
Matheus FernandesInstituto Carlos Chagas, Fiocruz Parana, Curitiba, Parana, Brazil.ORCID 0000-0003-4316-8412
Lyris Martins Franco de GodoyInstituto Carlos Chagas, Fiocruz Parana, Curitiba, Parana, Brazil. lyris.godoy@fiocruz.br.
Fundação Carlos Chagas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In humans and other eukaryotes, histone post-translational modifications (hPTMs) play an essential role in the epigenetic control of gene expression. In trypanosomatid parasites, conversely, gene regulation occurs mainly at the post-transcriptional level. However, our group has recently shown that hPTMs are abundant and varied in Trypanosoma cruzi, the etiological agent of Chagas Disease, signaling for possible conserved epigenetic functions. Here, we applied an optimized mass spectrometry-based proteomic workflow to provide a high-confidence comprehensive map of hPTMs, distributed in all canonical, variant and linker histones of T. cruzi. Our work expands the number of known T. cruzi hPTMs by almost 2-fold, representing the largest dataset of hPTMs available to any trypanosomatid to date, and can be used as a basis for functional studies on the dynamic regulation of chromatin by epigenetic mechanisms and the selection of candidates for the development of epigenetic drugs against trypanosomatids.

Indexed as

Protein Processing, Post-TranslationalChagas DiseaseChromatinDrug DevelopmentEpigenesis, GeneticHistonesHumansMass SpectrometryProteomicsProtozoan ProteinsTrypanocidal AgentsTrypanosoma cruziChromatinHistonesProtozoan ProteinsTrypanocidal Agents

Identifiers

PMID33767201
PMCPMC7994815
OpenAlexW3136153980

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.